Literature DB >> 7302917

Turnover of human histidine-rich glycoprotein in healthy subjects and during thrombolytic therapy.

H R Lijnen, F DeCock, D Collen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7302917     DOI： 10.1016/0049-3848(81)90245-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.

Authors:  N N Gorgani; J G Altin; C R Parish
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

Review 2.  Novel aspects of sepsis pathophysiology: NETs, plasma glycoproteins, endotheliopathy and COVID-19.

Authors:  M Nishibori
Journal:  J Pharmacol Sci       Date:  2022-06-15       Impact factor: 3.578

3.  Interaction of histidine-rich glycoprotein with fibrinogen and fibrin.

Authors:  L L Leung
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

4.  Histidine-rich glycoprotein uptake and turnover is mediated by mononuclear phagocytes.

Authors:  Sònia Tugues; Francis Roche; Oriol Noguer; Anna Orlova; Sujata Bhoi; Narendra Padhan; Peter Akerud; Satoshi Honjo; Ram Kumar Selvaraju; Massimiliano Mazzone; Vladimir Tolmachev; Lena Claesson-Welsh
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.